The Application Value of Spectral CT in the Accurate Staging of Breast Cancer
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 150
- 主要终点
- Pathological TNM staging
研究概览
简要总结
Spectral CT was used to prospectively collect medical images and clinical data related to breast cancer, evaluate the effect of image quality in the diagnosis of breast cancer, and evaluate the application value in the accurate staging of breast cancer, so as to provide a more accurate clinical basis for diagnosis, promote the development of individualized treatment, and ultimately improve the prognosis of patients.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Diagnostic
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •(a) Chest quark energy spectrum CT examination was performed within 1 week before treatment
- •(b) Age ≥ 18
- •(c) Suspected breast cancer patients
- •(d) Patients who signed informed consent
排除标准
- •(a) Severe cardiac, pulmonary and renal insufficiency
- •(b) Allergic to iodine contrast media
- •(c) Unable to cooperate to complete CT examination
- •(d) Quark spectrum CT image is poor and cannot be used
- •(e) Male, pregnant and lactating female
- •(f) Combined with other tumor history
- •(g) Incomplete clinical and pathological data
- •(h) Pathologically confirmed non breast cancer
研究组 & 干预措施
The application value of spectral CT in the accurate staging of breast cancer
Prospectively collect medical images and clinical data related to breast cancer using Philips Quark CT equipment, and evaluate the diagnostic accuracy and clinical application value in the accurate staging of breast cancer. Patients diagnosed with breast cancer in Yunnan Provincial Cancer Hospital from April 2025 to May 2026 were consecutively included, and after scanning with Philips Quark CT, the TNM stage of breast cancer patients was assessed by two radiologists, and finally statistical analysis was performed.
干预措施: To explore the value of spectral CT in the diagnosis and treatment of breast cancer (Diagnostic Test)
结局指标
主要结局
Pathological TNM staging
时间窗: 1 day
Pathological examination information: The pathology results using surgery/biopsy data are the gold standard, and the depth of tumor invasion, lymph node metastasis, and distant metastasis are recorded
次要结局
未报告次要终点